Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients

H. Inoue, Hisamichi Aizawa, Satoru Fukuyama, S. Takata, Koichiro Matsumoto, M. Shigyo, H. Koto, N. Hara

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Cytokines are considered to play a role in the airway inflammation of bronchial asthma. We examined the cellular profile and cytokine levels in induced sputum samples obtained before and after treatment with beclomethasone dipropionate (BDP, 800 μg/day, for 4 weeks) in 12 mild to moderate asthmatic subjects who had not previously received inhaled glucocorticosteroids. Sputum was induced with a 20-min inhalation of 3% saline by an ultrasonic nebulizer. The freshly expectorated sputum separated from the saliva was analyzed for cell counts, for the concentration of interleukin-8 (IL-8), and for the concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF). The mean percentage of eosinophils in the sputum samples decreased significantly after BDP treatment, but no significant change in the percentage of neutrophils was observed. The mean IL-8 and GM-CSF levels also decreased significantly after treatment. The BDP treatment was associated with an increase in the mean peak expiratory flow (PEF) and with a decrease in the diurnal variation of PEF. These results suggest that inhaled steroids improve airway inflammation and lung function in asthmatics, presumably in part by inhibiting the synthesis of inflammatory cytokines such as IL-8 and GM-CSF.

Original languageEnglish
Pages (from-to)53-62
Number of pages10
JournalLung
Volume177
Issue number1
DOIs
Publication statusPublished - Jan 11 1999

Fingerprint

Sputum
Glucocorticoids
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-8
Cytokines
Beclomethasone
Nebulizers and Vaporizers
Therapeutics
Saliva
Eosinophils
Ultrasonics
Inhalation
Pneumonia
Neutrophils
Asthma
Cell Count
Steroids
Inflammation

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. / Inoue, H.; Aizawa, Hisamichi; Fukuyama, Satoru; Takata, S.; Matsumoto, Koichiro; Shigyo, M.; Koto, H.; Hara, N.

In: Lung, Vol. 177, No. 1, 11.01.1999, p. 53-62.

Research output: Contribution to journalArticle

Inoue, H. ; Aizawa, Hisamichi ; Fukuyama, Satoru ; Takata, S. ; Matsumoto, Koichiro ; Shigyo, M. ; Koto, H. ; Hara, N. / Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. In: Lung. 1999 ; Vol. 177, No. 1. pp. 53-62.
@article{e37a468781a340f195003b98f85813d3,
title = "Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients",
abstract = "Cytokines are considered to play a role in the airway inflammation of bronchial asthma. We examined the cellular profile and cytokine levels in induced sputum samples obtained before and after treatment with beclomethasone dipropionate (BDP, 800 μg/day, for 4 weeks) in 12 mild to moderate asthmatic subjects who had not previously received inhaled glucocorticosteroids. Sputum was induced with a 20-min inhalation of 3{\%} saline by an ultrasonic nebulizer. The freshly expectorated sputum separated from the saliva was analyzed for cell counts, for the concentration of interleukin-8 (IL-8), and for the concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF). The mean percentage of eosinophils in the sputum samples decreased significantly after BDP treatment, but no significant change in the percentage of neutrophils was observed. The mean IL-8 and GM-CSF levels also decreased significantly after treatment. The BDP treatment was associated with an increase in the mean peak expiratory flow (PEF) and with a decrease in the diurnal variation of PEF. These results suggest that inhaled steroids improve airway inflammation and lung function in asthmatics, presumably in part by inhibiting the synthesis of inflammatory cytokines such as IL-8 and GM-CSF.",
author = "H. Inoue and Hisamichi Aizawa and Satoru Fukuyama and S. Takata and Koichiro Matsumoto and M. Shigyo and H. Koto and N. Hara",
year = "1999",
month = "1",
day = "11",
doi = "10.1007/PL00007627",
language = "English",
volume = "177",
pages = "53--62",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients

AU - Inoue, H.

AU - Aizawa, Hisamichi

AU - Fukuyama, Satoru

AU - Takata, S.

AU - Matsumoto, Koichiro

AU - Shigyo, M.

AU - Koto, H.

AU - Hara, N.

PY - 1999/1/11

Y1 - 1999/1/11

N2 - Cytokines are considered to play a role in the airway inflammation of bronchial asthma. We examined the cellular profile and cytokine levels in induced sputum samples obtained before and after treatment with beclomethasone dipropionate (BDP, 800 μg/day, for 4 weeks) in 12 mild to moderate asthmatic subjects who had not previously received inhaled glucocorticosteroids. Sputum was induced with a 20-min inhalation of 3% saline by an ultrasonic nebulizer. The freshly expectorated sputum separated from the saliva was analyzed for cell counts, for the concentration of interleukin-8 (IL-8), and for the concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF). The mean percentage of eosinophils in the sputum samples decreased significantly after BDP treatment, but no significant change in the percentage of neutrophils was observed. The mean IL-8 and GM-CSF levels also decreased significantly after treatment. The BDP treatment was associated with an increase in the mean peak expiratory flow (PEF) and with a decrease in the diurnal variation of PEF. These results suggest that inhaled steroids improve airway inflammation and lung function in asthmatics, presumably in part by inhibiting the synthesis of inflammatory cytokines such as IL-8 and GM-CSF.

AB - Cytokines are considered to play a role in the airway inflammation of bronchial asthma. We examined the cellular profile and cytokine levels in induced sputum samples obtained before and after treatment with beclomethasone dipropionate (BDP, 800 μg/day, for 4 weeks) in 12 mild to moderate asthmatic subjects who had not previously received inhaled glucocorticosteroids. Sputum was induced with a 20-min inhalation of 3% saline by an ultrasonic nebulizer. The freshly expectorated sputum separated from the saliva was analyzed for cell counts, for the concentration of interleukin-8 (IL-8), and for the concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF). The mean percentage of eosinophils in the sputum samples decreased significantly after BDP treatment, but no significant change in the percentage of neutrophils was observed. The mean IL-8 and GM-CSF levels also decreased significantly after treatment. The BDP treatment was associated with an increase in the mean peak expiratory flow (PEF) and with a decrease in the diurnal variation of PEF. These results suggest that inhaled steroids improve airway inflammation and lung function in asthmatics, presumably in part by inhibiting the synthesis of inflammatory cytokines such as IL-8 and GM-CSF.

UR - http://www.scopus.com/inward/record.url?scp=0032925254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032925254&partnerID=8YFLogxK

U2 - 10.1007/PL00007627

DO - 10.1007/PL00007627

M3 - Article

C2 - 9835634

AN - SCOPUS:0032925254

VL - 177

SP - 53

EP - 62

JO - Lung

JF - Lung

SN - 0341-2040

IS - 1

ER -